Clarus Therapeutics and McGill University Announce Exclusive Worldwide Licensing Agreement To Develop and Commercialize Technology To Treat Rare Conditions Associated With Coenzyme-Q10 (Ubiquinone) Deficiencies Agreement to accelerate development of potential treatments for rare, endocrine, metabolic, and neurological conditions associated with primary and secondary ubiquinone deficiencies which belong to...

Alliance grant for McGill Professor and Canadian fusion energy company Three-year project funded in part by Natural Science and Engineering Research Council (NSERC) will help Canadian company demonstrate fusion energy in a commercially relevant environment, paving the...

American Lithium Process Testing Produces Lithium Carbonate From Claystone At TLC VANCOUVER, British Columbia, Sept. 10, 2020 (GLOBE NEWSWIRE) -- American Lithium Corp. (TSXV: LI) (OTCQB: LIACF) (Frankfurt: 5LA1) (“American Lithium” or the “Company”) a leading lithium exploration...